New trial using advanced MR Imaging to investigate effect of inhaled treatments for COPD 5th September 2016

A trial sponsored by Novartis will build on previous research involving STH Respiratory Medicine (Dr Rod Lawson) and the University of Sheffield (Prof Jim Wild). The trial will study the effects of a combination inhaled drug therapy (LABA/LAMA) in patients with chronic obstructive pulmonary disease. The effects of the drugs on patient’s lungs will be assessed using advanced imaging techniques at the University’s Department of Academic Radiology (RHH), which is the UK MR scanning centre for the trial. For further information please contact rod.lawson@sth.nhs.uk